Innovative Strategies for Drug Delivery to the Ocular Posterior Segment

Innovative and new drug delivery systems (DDSs) have recently been developed to vehicle treatments drugs the ocular posterior segment retina. New formulations technological developments, such as nanotechnology, novel matrices, non-traditional treatment strategies, open perspectives in this field. The aim of mini-review is highlight promising strategies reported current literature based on innovative routes overcome anatomical physiological barriers vitreoretinal structures. paper also describes challenges finding appropriate pertinent that provide safety efficacy problems related patient compliance, acceptability, effectiveness, sustained delivery. clinical application these experimental approaches can help pave way for standardizing use DDSs developing enhanced personalized therapeutic options pathologies.